Darlene Deptula-Hicks

2016 - Pieris Pharmaceuticals

In 2016, Darlene Deptula-Hicks earned a total compensation of $430.6K as Chief Financial Officer at Pieris Pharmaceuticals, a 55% decrease compared to previous year.

Compensation breakdown

Bonus$120,000
Salary$300,000
Other$10,600
Total$430,600

Deptula-Hicks received $300K in salary, accounting for 70% of the total pay in 2016.

Deptula-Hicks also received $120K in bonus and $10.6K in other compensation.

Rankings

In 2016, Darlene Deptula-Hicks' compensation ranked 11,684th out of 14,075 executives tracked by ExecPay. In other words, Deptula-Hicks earned more than 17.0% of executives.

ClassificationRankingPercentile
All
11,684
out of 14,075
17th
Division
Manufacturing
4,564
out of 5,489
17th
Major group
Chemicals And Allied Products
1,628
out of 1,895
14th
Industry group
Drugs
1,317
out of 1,538
14th
Industry
Pharmaceutical Preparations
1,022
out of 1,176
13th
Source: SEC filing on May 16, 2017.

Deptula-Hicks' colleagues

We found two more compensation records of executives who worked with Darlene Deptula-Hicks at Pieris Pharmaceuticals in 2016.

2016

Stephen Yoder

Pieris Pharmaceuticals

Chief Executive Officer

2016

Louis Matis

Pieris Pharmaceuticals

Chief Development Officer

News

You may also like